Nebulizer is a medical device which can convert the liquid medication into mist or aerosol. Nebulizer is primarily utilized for the treatment of respiratory diseases such as asthma, COPD and cystic fibrosis. Increasing prevalence of asthma, COPD and cystic fibrosis drives the global nebulizers market. Moreover, increasing geriatric population also accentuates the global market for nebulizers. In addition, rising government initiatives in developed nations such as U.S, U.K and Japan also supports the growth of this market. The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019.
The global nebulizers market is segmented based on product types into pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizer accounted for the largest market share of the global nebulizers market owing to its cost effective nature and easy to handle. Pneumatic nebulizers are further classified as vented and breath-actuated pneumatic nebulizers. In 2012, breath actuated pneumatic nebulizers segment accounted for the largest share of the global pneumatic nebulizers market due to factors such as cost effectiveness and efficient drug delivery. Moreover, the breath-actuated pneumatic nebulizers segment is expected to grow at the highest CAGR from 2013 to 2019 in the global pneumatic nebulizers market. Ultrasonic nebulizers are further segmented into standalone and portable ultrasonic nebulizers. Portable ultrasonic nebulizers accounted for the largest share as they are easy to handle and operate.
This exhaustive report includes 10 data tables and 23 figures to give readers a 360° view of the Nebulizers Market. Browse through this 79-page report to know what factors will shape the market during the period 2013-2019
North America accounted for the largest share in the global nebulizers market in 2012 owing to rising prevalence of respiratory diseases such as asthma, COPD and cystic fibrosis. In addition, increasing government initiatives in this region also supported the growth of nebulizers market in the North American region. Asia-Pacific was observed to be an emerging market for nebulizers and is expected to grow at the highest CAGR from 2013 to 2019. This growth was mainly attributed due to presence of large patient pool diagnosed with chronic diseases such as asthma and chronic pulmonary obstructive diseases (COPD) in this region. Also, manufacturers are expanding their operations in Asian countries such as India, China, Japan and South Korea. For example, Omron Healthcare, Inc., established its subsidiary in South Korea to sell its nebulizers in this region. Thus, all the above mentioned factors collectively supports the growth of nebulizers market in Asia-Pacific region. Some of the key players having presence in the global nebulizers market are Philips Healthcare, Omron Healthcare, GF Health Products, Inc. and PARI Respiratory, Inc.
Get accurate market forecast and analysis on The Nebulizers Market. Request a sample to stay abreast on the key trends impacting this market.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453